Exams
At CMIT, FibroScan® is available. This is a non-invasive, quick, and painless examination, widely validated by science and supported by thousands of scientific publications. It is now one of the main tools for the initial assessment and monitoring of multiple liver diseases, allowing for the estimation, without resorting to liver biopsy, of the presence of fat in the liver (steatosis) and the degree of liver "scarring" (fibrosis). This examination is based on the transmission of waves through liver tissue. Liver stiffness, expressed in objective values, helps to estimate the degree of fibrosis, while wave attenuation allows for the quantification of steatosis. However, the results should always be interpreted in relation to the underlying liver disease and the clinical context of each patient. FibroScan® has been widely used in the evaluation and monitoring of patients with steatotic liver disease (formerly known as "fatty liver"), both in the initial risk stratification and in the assessment of response to therapy. Its usefulness also extends to other pathologies, including viral, autoimmune, and metabolic liver diseases, alcohol consumption, and, in specialized centers, vascular diseases of the liver. Under certain circumstances, splenic elastography may also be performed, a complementary assessment that can help estimate the existence of clinically significant portal hypertension, that is, increased pressure in the abdominal vessels. This information can be particularly useful in the context of cirrhosis, some vascular diseases of the liver, and in evaluating the response to certain treatments. To perform the examination, a minimum fasting period of 3 hours is required. It is a simple, well-tolerated, and painless procedure that takes only a few minutes. One of the great advantages is that the result is available at the time of the examination, allowing for immediate integration into the clinical evaluation. In patients with fatty liver disease, FibroScan® is currently one of the most useful non-invasive methods for estimating liver fibrosis and is recommended as the preferred tool for secondary risk assessment, often outperforming isolated analytical scores such as FIB-4, especially when a more robust assessment is needed in patients more likely to have less accurate results with laboratory formulas, such as older people, those with diabetes, or obesity.
At CMIT, FibroScan® is available. This is a non-invasive, quick, and painless examination, widely validated by science and supported by thousands of scientific publications. It is now one of the main tools for the initial assessment and monitoring of multiple liver diseases, allowing for the estimation, without resorting to liver biopsy, of the presence of fat in the liver (steatosis) and the degree of liver "scarring" (fibrosis). This examination is based on the transmission of waves through liver tissue. Liver stiffness, expressed in objective values, helps to estimate the degree of fibrosis, while wave attenuation allows for the quantification of steatosis. However, the results should always be interpreted in relation to the underlying liver disease and the clinical context of each patient. FibroScan® has been widely used in the evaluation and monitoring of patients with steatotic liver disease (formerly known as "fatty liver"), both in the initial risk stratification and in the assessment of response to therapy. Its usefulness also extends to other pathologies, including viral, autoimmune, and metabolic liver diseases, alcohol consumption, and, in specialized centers, vascular diseases of the liver. Under certain circumstances, splenic elastography may also be performed, a complementary assessment that can help estimate the existence of clinically significant portal hypertension, that is, increased pressure in the abdominal vessels. This information can be particularly useful in the context of cirrhosis, some vascular diseases of the liver, and in evaluating the response to certain treatments. To perform the examination, a minimum fasting period of 3 hours is required. It is a simple, well-tolerated, and painless procedure that takes only a few minutes. One of the great advantages is that the result is available at the time of the examination, allowing for immediate integration into the clinical evaluation. In patients with fatty liver disease, FibroScan® is currently one of the most useful non-invasive methods for estimating liver fibrosis and is recommended as the preferred tool for secondary risk assessment, often outperforming isolated analytical scores such as FIB-4, especially when a more robust assessment is needed in patients more likely to have less accurate results with laboratory formulas, such as older people, those with diabetes, or obesity.
At CMIT, we offer outpatient polysomnography (level III) sleep studies , a non-invasive and clinically valuable test for evaluating respiratory changes during sleep, particularly obstructive sleep apnea syndrome.
Performed at home, in the context of normal sleep, this examination allows for the comfortable, practical, and reliable study of a set of fundamental parameters of nocturnal breathing, without the need for hospitalization or a stay in a sleep laboratory. In this way, it becomes possible to obtain relevant clinical information in the patient's natural environment, with greater comfort and simplicity.
This study is especially indicated for people with complaints such as habitual snoring , observed breathing pauses during the night, frequent awakenings, non-restorative sleep, daytime sleepiness, persistent fatigue, morning headaches, or difficulty concentrating. It may also be particularly important in patients who are overweight, have high blood pressure, increased cardiovascular risk, or a clinical suspicion of sleep-disordered breathing.
Using a portable, easy-to-use, and well-tolerated device, parameters such as respiratory flow, ventilatory effort, blood oxygenation, and heart rate are recorded overnight. Analysis of this data allows for the identification of clinically relevant changes and contributes decisively to diagnosis and therapeutic guidance.
The importance of this examination lies not only in the detection of a common and often underdiagnosed disease, but also in the possibility of early intervention in a condition that can significantly compromise quality of life, daily performance, and cardiovascular and metabolic health. Timely diagnosis can make all the difference in controlling symptoms, reducing associated risk, and improving the overall well-being of the patient.
At CMIT, this examination is performed as part of a rigorous, personalized, and patient-centered clinical approach. As with any complementary examination, the results must be interpreted in light of the clinical history, symptoms, and individualized medical assessment, ensuring a diagnostic and therapeutic decision tailored to each specific situation.
Level III polysomnographic sleep studies in an outpatient setting thus represent a modern, convenient, and clinically relevant solution in the management of sleep-related breathing disorders, combining technical expertise, comfort, and accessibility within the context of high-quality medicine.
At CMIT, we offer level III outpatient polysomnography, a non-invasive and clinically valuable test for evaluating respiratory changes during sleep, particularly obstructive sleep apnea syndrome. Performed at home, in the patient's usual sleep environment, this test allows for the comfortable, practical, and reliable study of a set of fundamental parameters of nocturnal breathing, without the need for hospitalization or a stay in a sleep laboratory. This makes it possible to obtain relevant clinical information in the patient's natural environment, with greater comfort and simplicity. The study is especially indicated for people with complaints such as habitual snoring, observed breathing pauses during the night, frequent awakenings, non-restorative sleep, daytime sleepiness, persistent fatigue, morning headaches, or difficulty concentrating. It may also be particularly important in patients who are overweight, have high blood pressure, increased cardiovascular risk, or clinical suspicion of sleep-disordered breathing. Using a portable, easy-to-use, and well-tolerated device, parameters such as respiratory flow, ventilatory effort, blood oxygenation, and heart rate are recorded overnight. Analysis of this data allows for the identification of clinically relevant changes and contributes decisively to diagnosis and therapeutic guidance. The importance of this examination lies not only in the detection of a frequent and often underdiagnosed disease, but also in the possibility of early intervention in a condition that can significantly compromise quality of life, daily performance, and cardiovascular and metabolic health. Timely diagnosis can make all the difference in symptom control, reduction of associated risk, and overall improvement in patient well-being. At CMIT, this examination is integrated into a rigorous, personalized, and patient-centered clinical approach. As with any complementary examination, the results should be interpreted in light of the clinical history, symptoms, and individualized medical assessment, ensuring a diagnostic and therapeutic decision tailored to each specific situation. Level III polysomnographic sleep studies in an outpatient setting thus represent a modern, convenient, and clinically relevant solution in the management of sleep-related breathing disorders, combining technical expertise, comfort, and accessibility within the context of high-quality medicine.
At CMIT, we offer level III outpatient polysomnography, a non-invasive and clinically valuable test for evaluating respiratory changes during sleep, particularly obstructive sleep apnea syndrome. Performed at home, in the patient's usual sleep environment, this test allows for the comfortable, practical, and reliable study of a set of fundamental parameters of nocturnal breathing, without the need for hospitalization or a stay in a sleep laboratory. This makes it possible to obtain relevant clinical information in the patient's natural environment, with greater comfort and simplicity. The study is especially indicated for people with complaints such as habitual snoring, observed breathing pauses during the night, frequent awakenings, non-restorative sleep, daytime sleepiness, persistent fatigue, morning headaches, or difficulty concentrating. It may also be particularly important in patients who are overweight, have high blood pressure, increased cardiovascular risk, or clinical suspicion of sleep-disordered breathing. Using a portable, easy-to-use, and well-tolerated device, parameters such as respiratory flow, ventilatory effort, blood oxygenation, and heart rate are recorded overnight. Analysis of this data allows for the identification of clinically relevant changes and contributes decisively to diagnosis and therapeutic guidance. The importance of this examination lies not only in the detection of a frequent and often underdiagnosed disease, but also in the possibility of early intervention in a condition that can significantly compromise quality of life, daily performance, and cardiovascular and metabolic health. Timely diagnosis can make all the difference in symptom control, reduction of associated risk, and overall improvement in patient well-being. At CMIT, this examination is integrated into a rigorous, personalized, and patient-centered clinical approach. As with any complementary examination, the results should be interpreted in light of the clinical history, symptoms, and individualized medical assessment, ensuring a diagnostic and therapeutic decision tailored to each specific situation. Level III polysomnographic sleep studies in an outpatient setting thus represent a modern, convenient, and clinically relevant solution in the management of sleep-related breathing disorders, combining technical expertise, comfort, and accessibility within the context of high-quality medicine.
Coordinator: Professor Dr. Filipe Nery
Professor Dr. Filipe Nery